Curcumin and nano‐curcumin applications in psychiatric disorders

Psychiatric disorders cause long‐lasting disabilities across different age groups. While various medications are available for mental disorders, some patients do not fully benefit from them or experience treatment resistance. The pathogenesis of psychiatric disorders involves multiple mechanisms, in...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Phytotherapy research Ročník 38; číslo 8; s. 4240 - 4260
Hlavní autoři:	Mohammadzadeh, R., Fathi, M., Pourseif, M. M., Omidi, Y., Farhang, S., Barzegar Jalali, M., Valizadeh, H., Nakhlband, A., Adibkia, K.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Chichester, UK John Wiley & Sons, Ltd 01.08.2024 Wiley Subscription Services, Inc
Témata:	Animals Antidepressants Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use anxiety Anxiety disorders Anxiety Disorders - drug therapy Bipolar disorder Bipolar Disorder - drug therapy Clinical trials Curcumin Curcumin - chemistry Curcumin - pharmacology Curcumin - therapeutic use Depressive Disorder, Major - drug therapy Dosage Effectiveness Humans inflammation Inflammatory response Liposomes - chemistry Mental depression Mental disorders Mental Disorders - drug therapy nanocurcumin Nanoparticles Nanoparticles - chemistry Neuroprotection Pathogenesis phytotherapy psychiatric disorders Schizophrenia Schizophrenia - drug therapy Treatment resistance nanocurcumin curcumin psychiatric disorders
ISSN:	0951-418X, 1099-1573, 1099-1573
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!